HYDERABAD (Reuters) – The U.S. Meals and Drug Administration (FDA) is gathering data on merchandise of Indian spice makers MDH and Everest after Hong Kong halted gross sales of a few of their merchandise for allegedly containing excessive ranges of a cancer-causing pesticide.
“The FDA is aware of the reports and is gathering additional information about the situation,” an FDA spokesperson informed Reuters on Friday.
Hong Kong this month suspended gross sales of three MDH spice blends and an Everest spice combine for fish curries. Singapore ordered a recall of the Everest spice combine, saying it incorporates excessive ranges of ethylene oxide, which is unfit for human consumption and a most cancers danger with lengthy publicity.
MDH and Everest didn’t instantly reply to Reuters requests for remark. Everest has stated its spices are secure for consumption. MDH has not responded up to now.
MDH and Everest spices, that are among the many hottest names in India and are additionally offered in Europe, Asia and North America, are additionally below the Indian regulator’s scanner for high quality requirements, following Hong Kong and Singapore’s strikes.
